Isotiorga

Isotretinoin, the active ingredient in Isotiorga, is a retinoid presented as an oral capsule for oral use. It is indicated for the treatment of severe nodular acne and acne vulgaris that has not responded to other therapies, helping to reduce lesions and prevent new nodule formation.

GNH USA supplies Isotiorga as a licensed, GDP‑compliant international pharmaceutical supplier, providing EU‑origin medication to hospitals, pharmacies and clinics worldwide, with full regulatory documentation and cold‑chain logistics where required. All shipments comply with international quality standards and are supported by a dedicated technical service team.

Isotretinoin acts on the retinoid pathway to treat severe forms of acne.

Severe nodular acne: reduces existing lesions, prevents formation of new nodules, and improves skin appearance. Acne vulgaris refractory to other therapies: provides significant clearance when conventional treatments have failed. Cystic acne: decreases inflammatory lesions and sebum production.

Isotretinoin may cause a range of adverse reactions.

Common Side Effects: - Dry skin and mucous membranes - Cheilitis (lip inflammation) - Elevated triglyceride levels - Increased photosensitivity

Serious or Rare Side Effects: - Severe depression or suicidal thoughts - Hepatotoxicity with elevated liver enzymes - Teratogenic birth defects (Category X) - Pseudotumor cerebri (intracranial hypertension)

Use of Isotiorga requires careful monitoring and patient counseling. - Pregnancy: contraindicated; effective contraception must be used throughout treatment and for one month after cessation. - Liver function: obtain baseline tests and monitor periodically. - Lipid profile: assess baseline and follow‑up triglycerides and cholesterol. - Vitamin A: avoid concomitant vitamin A supplementation or other systemic retinoids. - Storage: Store below 25°C: keep in the original pack, protect from moisture.

Isotiorga can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity. - Other systemic retinoids: excessive toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in efficacy. - Corticosteroids: heightened risk of psychiatric side effects. - Ketoconazole and other azole antifungals: may raise isotretinoin plasma levels. - Lipid‑lowering agents: monitor lipid parameters closely.